We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-₹100 crore acquisition market, sized. Read it →
Solvent wind-down · IBC Section 59

Masters Biopharma (India) Private Limited

U36912MH2011FTC222075 · Company
Active
Liquidation outcome · IBC s.59
Realisation of assets
Amount due to creditors
Amount paid to creditors
Liquidation expenses
Surplus to members
Commenced
27 Apr 2026
Dissolved
Solvent voluntary liquidation under IBC Section 59 — a healthy company choosing to wind up. Creditors are paid in full and costs met before any surplus returns to members; there is no haircut or acquirer.
Company · MCA master
MCA status
Active
Company class
Private
Category
Company limited by shares
Sub-category
subsidiary of company incorporated outside India
Listing
Unlisted
Incorporated
16 Sep 2011
Authorised capital
₹5.00 L
Paid-up capital
₹1.22 L
ROC
ROC Mumbai
Industry
Manufacturing (Others)
PIN
400059
Registered office
Skyline Icon, 7th Floor, CTS No. 1628/A, 162,,Marol Village, Chimatpada, JB Nagar, Marol, Andheri East,Mumbai,Mumbai,Maharashtra,400059-India
Liquidator
ICSI IIP
IBBI/IPA-002/IP-N00269/2017-18/10782
View full RP profile →

Full voluntary-liquidation records — realisation, payout and surplus across every quarter — are part of the Full Investor Desk.

Apply for access →

See plans →

← All voluntary liquidations